<html>
<head>
  <title>2B6</title>
<style>
  .td {font-family: "verdana"; font-size: "10px"; color: "navy";}
  .green {background-color:"#ACA899";font-family:verdana; font-size:8pt;}
  .lite {background-color:"#F1EFE2";font-family:verdana; font-size:8pt; color:"#666600";}
  A:link {COLOR: "navy"; text-decoration: none;}
  A:visited {COLOR: "navy"; text-decoration: none;}
  A:active {COLOR: "navy"; text-decoration: none;}
  A:hover {COLOR:"#66CCFF";}
</style>
</head>

<body bgcolor="#FFFFFF">
<CENTER>
	<TABLE class="green" border="0" cellPadding="5" cellSpacing="1" width="600">

	
	<tr class="lite"><td>
	<b>References for Cytochrome P450 Drug Interaction Table</b><br>
	Part 2 of 7: 2B6 Isoform<br><br>
	

These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive <a HREF="index.htm">research-oriented table</a> and the concise <a HREF="clinlist.htm"> clinical table</a>). Most of these citations are hyperlinks, which bring up the abstract in the NLM's <i>PubMed<sup>®</sup></i> database.
	
<p>
Click on the <font COLOR="Blue"><i><u>PubMed</u></i></font> link after the drug name to perform a live MedLINE search of articles possibly related to that drug and
Cytochrome P450.</p>

<p>
Entries are organized by mode of activity (substrate, inhibitor, inducer)
within specific isoform. You can quickly branch to a section by clicking
on the appropriate link here:
</p>

<center>
  <table ALIGN="Center" cellpadding="5" cellspacing="1" border="0">
    <tr>
      <td class="td"><p ALIGN="Right">1A2:</td>
      <td class="td"><a HREF="1A2.htm#1A2sub">Substrates</a></td>
      <td class="td"><a HREF="1A2.htm#1A2inh">Inhibitors</a></td>
      <td class="td"><a HREF="1A2.htm#1A2ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2B6:</td>
      <td class="td"><a HREF="2B6.htm#2B6sub">Substrates</a></td>
      <td class="td"><a HREF="2B6.htm#2B6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2B6.htm#2B6ind">Inducers</a></td>
      </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2C19:</td>
      <td class="td"><a HREF="2C19.htm#2C19sub">Substrates</a></td>
      <td class="td"><a HREF="2C19.htm#2C19inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C19.htm#2C19ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2C9:</td>
      <td class="td"><a HREF="2C9.htm#2C9sub">Substrates</a></td>
      <td class="td"><a HREF="2C9.htm#2C9inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C9.htm#2C9ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2D6:</td>
      <td class="td"><a HREF="2D6.htm#2D6sub">Substrates</a></td>
      <td class="td"><a HREF="2D6.htm#2D6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2D6.htm#2D6ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2E1:</td>
      <td class="td"><a HREF="2E1.htm#2E1sub">Substrates</a></td>
      <td class="td"><a HREF="2E1.htm#2E1inh">Inhibitors</a></td>
      <td class="td"><a HREF="2E1.htm#2E1ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">3A4,5,7:</td>
      <td class="td"><a HREF="3A457.htm#3A457sub">Substrates</a></td>
      <td class="td"><a HREF="3A457.htm#3A457inh">Inhibitors</a></td>
      <td class="td"><a HREF="3A457.htm#3A457ind">Inducers</a></td>
    </tr>
  </table>
  </center>

<p>
Hint: a quick way to find a specific reference on this page is to use your web browser's Search feature: press Ctrl-F and type all or part of the name or word for which you are searching.</p>
<p>
  <hr>

  <a NAME="2B6sub"><img src="2B6substrates.jpg"></a>

<p>
<a NAME="2B6bupropion"><b>bupropion</b></a>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+bupropion&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.</i><br>
Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM.<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10997944&dopt=Abstract">Drug Metab Dispos 2000 Oct;28(10):1222-30</a>
<p>
<a NAME="2B6cylophosphamide"><b>cyclophosphamide</b></a>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cyclophosphamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.</i><br>
Chang TK, Weber GF, Crespi CL, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8242617&dopt=Abstract">
Cancer Res 1993 Dec 1;53(23):5629-37.</a>
<p>
<a NAME="2B6ifosphamide"><b>ifosphamide</b></a>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ifosphamide&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.</i><br>
Chang TK, Weber GF, Crespi CL, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8242617&dopt=Abstract">
Cancer Res 1993 Dec 1;53(23):5629-37.</a><br>
<p>
<i>Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.</i><br>
Granvil CP, Madan A, Sharkawi M, Parkinson A, Wainer IW<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10101149&dopt=Abstract">
Drug Metab Dispos 1999 Apr;27(4):533-41.</a>

  <hr>

<a NAME="2B6inh"><img src="2B6inhibitors.jpg"></a>

<p>
<b><a NAME="2B6thiotepa">thiotepa</a></b>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+thiotepa&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: Implications for cyclophosphamide metabolism.</i><br>
Rae JM, Soukhova NV, Flockhart DA, Desta Z<br>
<a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11950782&dopt=Abstract">
Drug Metab Dispos 2002;30(5)</a>
<p>

<b><a NAME="2B6Ticlopidine">ticlopidine</a></b>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ticlopidine&doptcmdl=DocSum">PubMed</a></i>
<p>

  <hr>
<a NAME="2B6ind"><img src="2B6inducers.jpg"></a>

<p>
<b><a NAME="2B6phenobarbital">phenobarbital</a></b>: Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+phenobarbital&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.</i><br>
Chang TK, Yu L, Maurel P, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9157990&dopt=Abstract">
Cancer Res 1997 May 15;57(10):1946-54</a>
<p>
<b><a NAME="2B6phenytoin">phenytoin</a></b>:Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+phenytoin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.</i><br>
Ducharme MP, Bernstein ML, Granvil CP, Gehrcke B, Wainer IW<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9332469&dopt=Abstract">
Cancer Res 1997 May 15;40(6):531-3</a>
<p>
<b><a NAME="2B6rifampin">rifampin</a></b>:Info
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+rifampin&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.</i><br>
Chang TK, Yu L, Maurel P, Waxman DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9157990&dopt=Abstract">
Cancer Res 1997 May 15;57(10):1946-54</a>
<p>
</body></html>
